Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

2018 Pan Pacific Lymphoma Conference
C

There is a Role for Lymphoma HDT/ASCT in the New Era of CAR T-cells!

By 2018 Pan Pacific Lymphoma Conference FEATURING Craig Moskowitz
By 2018 Pan Pacific Lymphoma Conference FEATURING Craig Moskowitz
202 views
August 23, 2018
0 Comments
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi
High Grade B-cell Lymphoma
19:22
2018 Pan Pacific Lymphoma Conference

Challenges of Treating HGBCL Patients with Comorbidities: Anthracycl…

Feat. L. Sehn
17:51
2018 Pan Pacific Lymphoma Conference

Optimum Therapy for Standard Risk High Grade - DLBCL

Feat. N. Bartlett
10:46
2018 Pan Pacific Lymphoma Conference

New Approaches to Initial treatment of DLBCL: R-CHOP +

Feat. N. Bartlett
15:30
2018 Pan Pacific Lymphoma Conference

Challenges of Treating HGBCL Patients with Comorbidities: Who is &qu…

Feat. L. Sehn
21:17
2018 Pan Pacific Lymphoma Conference

Burkitt Lymphoma- R-Epoch for All?

Feat. M. Roschewski
08:52
2018 Pan Pacific Lymphoma Conference

Concurrent Systemic and CNS Aggressive NHL: How to Manage?

Feat. P. Bierman
26:03
2018 Pan Pacific Lymphoma Conference

Therapy for Double/Triple Hit-HGBCL

Feat. S. Smith
25:59
2018 Pan Pacific Lymphoma Conference

There is a Role for Lymphoma HDT/ASCT in the New Era of CAR T-cells!

Feat. C. Moskowitz
16:20
2018 Pan Pacific Lymphoma Conference

Is there a role for upfront transplantation in CNS Aggressive NHL

Feat. P. Bierman